What Drives the Demand in the Insulin Pump Market by 2032?

SkyQuest Market Research

SkyQuest Technology Group has recently published a comprehensive Insulin Pump Market report, offering a detailed analysis of the product landscape and industry scope while providing insights into the market outlook and future trends from 2025 to 2032. This study segments the market across major regions, each contributing to the growing momentum of market development. Insulin pumps are compact, computerised devices that are programmed to administer a diabetic patient’s prescribed amounts of insulin. The demand for portable insulin delivery systems among the diabetic community has increased, and the Insulin Pump Market has grown and developed in recent years to meet this demand.

Global Insulin Pump Market size was valued at USD 6.05 billion in 2023 and is poised to grow from USD 6.55 billion in 2024 to USD 12.3 billion by 2032, growing at a CAGR of 8.2% during the forecast period (2025-2032).

The global Insulin Pump Market is expanding at a large rate due to the population’s fast increasing prevalence of diabetes and growing understanding of how to treat it. The International Diabetes Federation (IDF) estimates that there were 537 million people with diabetes worldwide in 2019, and that figure is predicted to climb to 783 million by the year 2045. According to the World Health Organization, diabetes can result in blindness, renal failure, and stroke. The Insulin Pump Market is expanding at a rapid rate due to factors including growing healthcare costs, easier access to healthcare facilities, and the widespread availability of sophisticated insulin pumps.

Get a Free Sample PDF of the Report – https://www.skyquestt.com/sample-request/insulin-pump-market

Detailed Segmentation and Classification of the report (Market Size and Forecast – 2032, Y-o-Y growth rate, and CAGR):
The Insulin Pump Market can be segmented based on several factors, including product type, application, end-user, and distribution channel.

Global Insulin Pumps Market is segmented by Type, Component, Disease Indication, Type of Therapy, Usage Type, Patient Demographics, Distribution Channel and region.

Based on Type, the market is segmented into Tethered Insulin Pumps, Patch Pumps (Tubeless Pumps), Miniature/Implantable Pumps and Smart Insulin Pumps.
Based on Component, the market is segmented into Pump Device, Infusion Set (Cannula & Tubing), Reservoir or Cartridge, Battery and Power Systems and Control System & Software.
Based on Disease Indication, the market is segmented into Type 1 Diabetes and Type 2 Diabetes.
Based on Type of Therapy, the market is segmented into Conventional Insulin Therapy, Continuous Subcutaneous Insulin Infusion (CSII), Automated Insulin Delivery (AID) or Closed Loop Systems and Hybrid Closed Loop Systems.
Based on Usage Type, the market is segmented into Reusable Insulin Pumps and Disposable Insulin Pumps.
Based on Patient Demographics, the market is segmented into Pediatric (0–17 years), Adult (18+ years) and Geriatric (65+ years).
Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Direct Sales.
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Insulin Pump Market – Regional Analysis:

The global Insulin Pump Market includes recent trends and potential prospects for each region, including Europe, North America, Asia Pacific (APAC), the Middle East, and Africa (MEA). Due to the increased prevalence of diabetes, North America will dominate the market for these throughout the projection period. In addition, the presence of major industry players in the area, the rising obesity rate, the accessibility of cutting-edge medical facilities, the high consumption of fast food, technological advancements, and consumers’ sedentary lifestyles all contribute to market growth.

Europe is expected to hold the second-largest share of the worldwide insulin pump market during the projected period due to the presence of numerous key market players there, the availability of cutting-edge medical facilities, and technological advances. The region’s national markets include the UK, Spain, Italy, Germany, and France.

Over the course of the forecasted period, it is expected that the APAC region would witness rapid growth in the worldwide insulin pump market. Growing health consciousness, the availability of cutting-edge medical facilities, an increase in disposable income, better medical facilities in South Korea, Japan, Australia, India, and China, and an increase in the prevalence of diabetes in Taiwan, Malaysia, Indonesia, India, and China are some of the factors driving the market growth in the region.

Top Market Players in Insulin Pump Market are:

Medtronic
Tandem Diabetes Care
Insulet Corporation
Ypsomed
Roche Diabetes Care
Beta Bionics Inc.
Medtrum Technologies
B. Braun Melsungen AG
Sooil Development Co. Ltd.
Sequel Med Tech, LLC
Jiangsu Delfu Co., Ltd.
ViCentra B.V.
MicroTech Medical
PharmaSens
Microport Scientific
Debiotech S.A.

Recent Developments in Insulin Pump Market:

In February 2022, The FDA has approved Tandem Diabetes Care, Inc.’s mobile bolus functionality, which enables t:slim X2 customers to manage an insulin bolus through the t:connect mobile app on their own smartphone.

In May 2021, MySugr Pump Control was introduced by F. Hoffmann-La Roche Ltd. within the mySugr app. MySugr Pump Operate enables patients to immediately control their insulin pumps via smartphone in order to import and view data status.

In July 2021, The mylife YpsoPump system’s feature set has been expanded by Ypsomed AG. People with diabetes can continually manage their therapy via their smartphone thanks to this app-based integration of the Dexcom G6 Continuous Glucose Monitoring (CGM) System.

You may Also Like

https://issuu.com/skyquest-technology/docs/rum_market_growth_forecast_projected_revenue_incre
https://issuu.com/skyquest-technology/docs/what_s_driving_the_popularity_of_ginger_beer_in_th/s/88271079

Forward-Looking Insights

The Insulin Pump Market is set to experience sustained growth, fueled by technological advancements, broader global market access, and rising industry demand. With the industry addressing emerging challenges and capitalizing on new opportunities, it is expected to drive innovation and play a pivotal role in advancing global health and economic progress.

About Company:

SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.
We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia Pacific.

Contact Details:

SkyQuest Technology Group
USA (+1) 351-333-4748
Email: [email protected]

Skyquest Technology

Skyquest Technology

SkyQuest Technology Group is a global market intelligence, innovation management & commercialization organization that connects innovation to new markets, networks & collaborators for achieving sustainable development goals.